(Q58212599)
Statements
Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer (English)
B M Cantwell
J Carmichael
P Dawes
A Robinson
J Farndon
scientific article published on 01 July 1989
No description defined